Table 1.
Patient and healthy volunteer data
| Control (n = 6) | IPAH (n = 6) | |
|---|---|---|
| Males/females | 1/5. | 0/6 |
| Age, years | 27.5 (24.0–33.0) | 43.0 (27.0–67.0) |
| Time from diagnosis, months | … | 17.0 (0.1–60.0) |
| mPAP, mmHg | … | 67.0 (50.0–71.0) |
| 6MWD, m | … | 382.0 (0–438.0) |
| WHO class | ||
| 1 | … | 0 |
| 2 | … | 1 |
| 3 | … | 4 |
| 4 | … | 1 |
| Warfarin | … | 4 |
| Treatment naive | 1 | |
| Calcium channel blocker | 1 | |
| Endothelin receptor antagonist | … | 3 |
| PDE5 inhibitor | … | 4 |
| Prostanoid | … | 2 |
| Statin | … | 0 |
Note
Data are presented as median (range). IPAH: idiopathic pulmonary hypertension; mPAP: mean pulmonary artery pressure; 6MWD: 6-minute walk distance; WHO class: World Health Organization functional class; PDE5: phosphodiesterase type 5.